Related Experiment Video
Updated: Jul 17, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
[Qualitative detection of hepatitis C virus core antigen in the serum in patients with chronic hepatitis C]
Yi Ouyang1, De-ming Tan, Tie-gang Li
1Departerment of Infectious Disease, Xiangya Hospital, Central South University, Changsha 410078, China.
Insights
Serum hepatitis C virus (HCV) core antigen detected by ELISA shows high specificity and is related to HCV RNA. This marker may be useful for detecting HCV viraemia in patients with chronic hepatitis C.
Area of Science:
- Hepatology
- Virology
- Immunology
Context:
- Hepatitis C virus (HCV) infection remains a significant global health concern.
- Accurate and accessible diagnostic markers are crucial for managing chronic hepatitis C.
- Enzyme-linked immunosorbent assay (ELISA) is a widely used diagnostic technique.
Purpose:
- To evaluate the clinical significance of serum hepatitis C virus (HCV) core antigen detected by ELISA.
- To assess the specificity and correlation of HCV core antigen with HCV RNA and anti-HCV antibodies.
Summary:
- Serum HCV core antigen was detected using ELISA in 149 patients with chronic hepatitis C, 20 with chronic hepatitis B, and 20 healthy volunteers.
- HCV core antigen was negative in all patients with chronic hepatitis B and healthy volunteers, indicating high specificity.
- The positive rate of HCV core antigen in chronic hepatitis C patients was 49.66%, showing a correlation with HCV RNA levels.
Impact:
- HCV core antigen detected by ELISA demonstrates high specificity.
- The positive percentage of HCV core antigen in chronic hepatitis C patients is 49.66%.
- HCV core antigen serves as a potential serum marker for detecting HCV viraemia, similar to HCV RNA.
Objective:
To evaluate the clinical significance of serum hepatitis C virus (HCV) core antigen detected by enzyme linked immunosorbent assay (ELISA).
Methods:
The serum HCV core antigen, which was taken from 149 patients with chronic hepatitis C, 20 patients of chronic hepatitis B and 20 health volunteers, was detected by ELISA. Meanwhile, the serum HCV RNA was detected by RT-PCR, and anti-HCV was detected by ELISA.
Results:
The qualitative HCV core antigen in the serum, which was take from 20 patients of chronic hepatitis B and 20 health volunteers, was negative.The positive percentage of HCV core antigen was 49.66% in the 149 sera of patients with chronic hepatitis C. The coincidence of detective results of HCV RNA and HCV core antigen was 54.36%, without significant difference (P>0.05). The positive percentage of HCV RNA and HCV core antigen in the 149 anti-HCV antibody positive sera samples were 55.03% (82/149) and 49.66% (74/149), respectively, and there was no significant difference (P>0.05).
Conclusion:
The qualitative HCV core antigen detected by ELISA has a high specificity. The positive percentage of HCV core antigen in the serum of patients with chronic hepatitis C is 49.66%. HCV core antigen is related to HCV RNA. HCV core antigen may be a useful serum marker which could show HCV viraemia like HCV RNA.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Enzyme-Linked Immunosorbent Assay
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
Cytomegalovirus Disease
Hepatic Encephalopathy

